Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,313 warrant series at 1,052 companies. 775 in the money, 58 expiring in the next 30 days, 36 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| December 28, 2020 ten-year warrants ($20.00) - Dickerson / Patel | $0.4766 | $3.6M | 10-K, Mar 20, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| December 7, 2021 Roth Underwriter's Warrant ($5.1625, pre-2023-split basis) | $0.4766 | $3.6M | 8-K EX-4.1, Dec 7, 2021Dilution tabAs of Nov 9, 2026 | ||||||||
| July 15, 2021 ten-year warrants ($150.00) - Dickerson / Patel / Ichim | $0.4766 | $3.6M | 10-K, Mar 20, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| June 30, 2026 Inducement Warrants ($1.60) | $0.4766 | $3.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| March 2025 Roth Advisor Warrant ($3.75) | $0.4766 | $3.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| March 6, 2025 Inducement Warrants ($3.75) - unexercised remainder | $0.4766 | $3.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 2024 Placement Agent Warrants ($4.42) | $0.4766 | $3.6M | 424B5, Oct 23, 2024Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2020 consultant three-year warrant ($14.50) | $0.4766 | $3.6M | 10-K, Mar 20, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Unitemized residual of September 30, 2026 warrant table (incl. Dec 2021 / May 2022 warrants repriced to $4.73 and other legacy warrants) | $0.4766 | $3.6M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| August 2022 Private Placement Unit Warrants ($15.00) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Boustead Follow-On Representative Warrants ($5.70) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Boustead IPO Representative Warrants ($75.00) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Boustead Over-Allotment Representative Warrant ($5.63) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| December 2025 Private Placement Warrants ($1.4245) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Indigo Capital Holder Warrants ($1.815) | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2025 Investor Warrants ($3.00) | $0.1600 | $3.6M | 10-K, Apr 1, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2026 Registered Direct Common Warrants ($1.00) | $0.1600 | $3.6M | 424B5, Oct 9, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Repriced $1.50 SPA Warrants (April/June 2024, December 2024 and January 2025 series) — unexercised remainder | $0.1600 | $3.6M | 10-K, Apr 1, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Tiger Cub Trust Warrants | $0.1600 | $3.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Outstanding warrants (aggregate, as stated in F-3 base prospectus) | $1.61 | $3.6M | F-3/A, Nov 9, 2023Dilution tabAs of Oct 5, 2026 | ||||||||
| Placement Agent Warrants (Craft Capital Management LLC, February 2025 registered offering) | $1.61 | $3.6M | 20-F, Apr 24, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| June 2026 Pre-Funded Warrants | $0.8301 | $3.5M | POS AM, Aug 13, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Rights offering Pre-Funded Warrants (August 2025) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Rights offering Warrants (August 2025) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B Warrants (March 2026, amended - Armistice) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B Warrants (March 2026, original terms) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series C Warrants (March 2026, amended - Armistice) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series C Warrants (March 2026, original terms) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series D Warrants (June 2026) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series E Warrants (June 2026) | $0.8301 | $3.5M | 6-K EX-99.1, Aug 12, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| July 2024 Common Warrants | $1.71 | $3.5M | 10-K, Mar 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| July 2024 Placement Agent Warrants | $1.71 | $3.5M | S-1, Aug 21, 2024Dilution tabAs of Nov 14, 2026 | ||||||||
| July 2026 Placement Agent Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| July 2026 Series A-3 Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| July 2026 Series A-4 Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2024 Common Warrants | $1.71 | $3.5M | 10-K, Mar 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2024 Placement Agent Warrants | $1.71 | $3.5M | 10-K, Mar 27, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Placement Agent Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Series A-1 Common Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Series A-2 Common Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2026 Pre-Funded Warrants | $1.71 | $3.5M | 8-K, Nov 6, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Placement Agent Warrants | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Warrants (concurrent private placement) | $1.71 | $3.5M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants at $6.25 per share (pre-2024 series, not itemised) | $1.71 | $3.5M | 424B3, Apr 14, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Direct offering March 2024 warrants | $1.93 | $3.5M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Direct offering October 2024 warrants | $1.93 | $3.5M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| IPO non-tradeable warrants | $1.93 | $3.5M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| IPO tradeable warrants (BIAFW) | $1.93 | $3.5M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 2026 Placement Agent Warrants | $1.93 | $3.5M | 8-K, Oct 9, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| PIPE/Inducement offering August 2025 warrants | $1.93 | $3.5M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 |
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
December 28, 2020 ten-year warrants ($20.00) - Dickerson / Patel
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
December 7, 2021 Roth Underwriter's Warrant ($5.1625, pre-2023-split basis)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
July 15, 2021 ten-year warrants ($150.00) - Dickerson / Patel / Ichim
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
June 30, 2026 Inducement Warrants ($1.60)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
March 2025 Roth Advisor Warrant ($3.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
March 6, 2025 Inducement Warrants ($3.75) - unexercised remainder
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
October 2024 Placement Agent Warrants ($4.42)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
September 2020 consultant three-year warrant ($14.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
CELZCreative Medical Technology Holdings, Inc.$0.4766Last price
Unitemized residual of September 30, 2026 warrant table (incl. Dec 2021 / May 2022 warrants repriced to $4.73 and other legacy warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
August 2022 Private Placement Unit Warrants ($15.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Boustead Follow-On Representative Warrants ($5.70)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Boustead IPO Representative Warrants ($75.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Boustead Over-Allotment Representative Warrant ($5.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
December 2025 Private Placement Warrants ($1.4245)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Indigo Capital Holder Warrants ($1.815)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
May 2025 Investor Warrants ($3.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
October 2026 Registered Direct Common Warrants ($1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Repriced $1.50 SPA Warrants (April/June 2024, December 2024 and January 2025 series) — unexercised remainder
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
MGRXMangoceuticals, Inc.$0.1600Last price
Tiger Cub Trust Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
Outstanding warrants (aggregate, as stated in F-3 base prospectus)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
Placement Agent Warrants (Craft Capital Management LLC, February 2025 registered offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.6M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
June 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Rights offering Pre-Funded Warrants (August 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Rights offering Warrants (August 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series B Warrants (March 2026, amended - Armistice)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series B Warrants (March 2026, original terms)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series C Warrants (March 2026, amended - Armistice)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series C Warrants (March 2026, original terms)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series D Warrants (June 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
ICCMIceCure Medical Ltd. Ordinary Shares$0.8301Last price
Series E Warrants (June 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
July 2024 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
July 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
July 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
July 2026 Series A-3 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
July 2026 Series A-4 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
June 2024 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
June 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
May 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
May 2025 Series A-1 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
May 2025 Series A-2 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
November 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
October 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
October 2025 Warrants (concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
SILOSilo Pharma, Inc.$1.71Last price
Warrants at $6.25 per share (pre-2024 series, not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
Direct offering March 2024 warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
Direct offering October 2024 warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
IPO non-tradeable warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
IPO tradeable warrants (BIAFW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
October 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
BIAFbioAffinity Technologies, Inc.$1.93Last price
PIPE/Inducement offering August 2025 warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$3.5M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,860 of 5,313 series state an exercise price and 3,369 an expiry date. 147 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.